Catalyst Pharma rises after upgrading annual revenue forecast
10/08/2023 13:11
** Shares of drug developer Catalyst Pharmaceuticals Inc
CPRX.O rise 8.9% to $15.38 premarket
** Co late on Wednesday raised full-year revenue forecast
** Q2 revenue surged ~88% Y/Y on increased sales of
neuromuscular disorder drug and an antiepileptic drug acquired
earlier this year
** Up to last close, stock down 24% this year
(Reporting by Mariam Sunny in Bengaluru)
((Mariam.ESunny@thomsonreuters.com;))